Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cells ; 10(9)2021 08 28.
Article in English | MEDLINE | ID: mdl-34571878

ABSTRACT

Parkinson's disease (PD) is the most prevalent movement disorder characterized with loss of dopaminergic neurons in the brain. One of the pathological hallmarks of the disease is accumulation of aggregated α-synuclein (αSyn) in cytoplasmic Lewy body inclusions that indicates significant dysfunction of protein homeostasis in PD. Accumulation is accompanied with highly elevated S129 phosphorylation, suggesting that this posttranslational modification is linked to pathogenicity and altered αSyn inclusion dynamics. To address the role of S129 phosphorylation on protein dynamics further we investigated the wild type and S129A variants using yeast and a tandem fluorescent timer protein reporter approach to monitor protein turnover and stability. Overexpression of both variants leads to inhibited yeast growth. Soluble S129A is more stable and additional Y133F substitution permits αSyn degradation in a phosphorylation-independent manner. Quantitative cellular proteomics revealed significant αSyn-dependent disturbances of the cellular protein homeostasis, which are increased upon S129 phosphorylation. Disturbances are characterized by decreased abundance of the ubiquitin-dependent protein degradation machinery. Biotin proximity labelling revealed that αSyn interacts with the Rpt2 base subunit. Proteasome subunit depletion by reducing the expression of the corresponding genes enhances αSyn toxicity. Our studies demonstrate that turnover of αSyn and depletion of the proteasome pool correlate in a complex relationship between altered proteasome composition and increased αSyn toxicity.


Subject(s)
Proteasome Endopeptidase Complex/metabolism , Saccharomyces cerevisiae/metabolism , Ubiquitin/metabolism , alpha-Synuclein/metabolism , Chromatography, High Pressure Liquid , Down-Regulation , Genotype , Humans , Mass Spectrometry , Mutagenesis, Site-Directed , Parkinson Disease/metabolism , Parkinson Disease/pathology , Phosphorylation , Proteasome Endopeptidase Complex/genetics , Protein Subunits/genetics , Protein Subunits/metabolism , Proteome/analysis , Saccharomyces cerevisiae/genetics , alpha-Synuclein/genetics
2.
FASEB J ; 35(7): e21695, 2021 07.
Article in English | MEDLINE | ID: mdl-34160101

ABSTRACT

Chronic wounds are a major disease burden worldwide. The breach of the epithelial barrier facilitates transition of skin commensals to invasive facultative pathogens. Therefore, we investigated the potential effects of Staphylococcus aureus (SA) on dermal fibroblasts as key cells for tissue repair. In co-culture systems combining live or heat-killed SA with dermal fibroblasts derived from the BJ-5ta cell line, healthy individuals, and patients with systemic sclerosis, we assessed tissue repair including pro-inflammatory cytokines, matrix metalloproteases (MMPs), myofibroblast functions, and host defense responses. Only live SA induced the upregulation of IL-1ß/-6/-8 and MMP1/3 as co-factors of tissue degradation. Additionally, the increased cell death reduced collagen production, proliferation, migration, and contractility, prerequisite mechanisms for wound closure. Intracellular SA triggered inflammatory and type I IFN responses via intracellular dsDNA sensor molecules and MyD88 and STING signaling pathways. In conclusion, live SA affected various key tissue repair functions of dermal fibroblasts from different sources to a similar extent. Thus, SA infection of dermal fibroblasts should be taken into account for future wound management strategies.


Subject(s)
Fibroblasts/pathology , Skin Diseases, Infectious/pathology , Skin/pathology , Staphylococcal Infections/complications , Staphylococcus aureus/pathogenicity , Wound Healing , Adult , Aged , Case-Control Studies , Cell Movement , Cell Proliferation , Cells, Cultured , Female , Fibroblasts/microbiology , Humans , Male , Middle Aged , Skin/microbiology , Skin Diseases, Infectious/microbiology , Staphylococcal Infections/microbiology , Young Adult
3.
Front Microbiol ; 11: 1415, 2020.
Article in English | MEDLINE | ID: mdl-32695082

ABSTRACT

Staphylococcus aureus causes chronic and relapsing infections, which may be difficult to treat. So-called small colony variants (SCVs) have been associated with chronic infections and their occurrence has been shown to increase under antibiotic pressure, low pH and intracellular localization. In clinics, S. aureus isolated from invasive infections often show a dysfunction in the accessory gene regulator (agr), a major virulence regulatory system in S. aureus. To assess whether intracellular environment and agr function influence SCV formation, an infection model was established using lung epithelial cells and skin fibroblasts. This allowed analyzing intracellular survival and localization of a panel of S. aureus wild type strains and their isogenic agr knock out mutants as well as a natural dysfunctional agr strain by confocal laser scanning microscopy (CLSM). Furthermore, bacterial colonies were quantified after 1, 3, and 5 days of intracellular survival by time-lapse analysis to determine kinetics of colony appearance and SCV formation. Here, we show that S. aureus strains with an agr knock out predominantly resided in a neutral environment, whereas wild type strains and an agr complemented strain resided in an acidic environment. S. aureus agr mutants derived from an intracellular environment showed a higher percentage of SCVs as compared to their corresponding wild type strains. Neutralizing acidic phagolysosomes with chloroquine resulted in a significant reduction of SCVs in S. aureus wild type strain 6850, but not in its agr mutant indicating a pH dependent formation of SCVs in the wild type strain. The in-depth understanding of the interplay between intracellular persistence, agr function and pH should help to identify new therapeutic options facilitating the treatment of chronic S. aureus infections in the future.

4.
Nat Commun ; 10(1): 1149, 2019 03 08.
Article in English | MEDLINE | ID: mdl-30850614

ABSTRACT

Treatment failure in biofilm-associated bacterial infections is an important healthcare issue. In vitro studies and mouse models suggest that bacteria enter a slow-growing/non-growing state that results in transient tolerance to antibiotics in the absence of a specific resistance mechanism. However, little clinical confirmation of antibiotic tolerant bacteria in patients exists. In this study we investigate a Staphylococcus epidermidis pacemaker-associated endocarditis, in a patient who developed a break-through bacteremia despite taking antibiotics to which the S. epidermidis isolate is fully susceptible in vitro. Characterization of the clinical S. epidermidis isolates reveals in-host evolution over the 16-week infection period, resulting in increased antibiotic tolerance of the entire population due to a prolonged lag time until growth resumption and a reduced growth rate. Furthermore, we observe adaptation towards an increased biofilm formation capacity and genetic diversification of the S. epidermidis isolates within the patient.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteremia/microbiology , Drug Resistance, Multiple/genetics , Endocarditis/microbiology , Host-Pathogen Interactions/genetics , Staphylococcal Infections/microbiology , Staphylococcus epidermidis/genetics , Adult , Bacteremia/drug therapy , Bacteremia/pathology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Biofilms/drug effects , Biofilms/growth & development , Drug Tolerance/genetics , Endocarditis/drug therapy , Endocarditis/pathology , Evolution, Molecular , Fluoroquinolones/pharmacology , Glycopeptides/pharmacology , Humans , INDEL Mutation , Male , Microbial Sensitivity Tests , Pacemaker, Artificial/microbiology , Peptides, Cyclic/pharmacology , Phylogeny , Polymorphism, Single Nucleotide , Staphylococcal Infections/drug therapy , Staphylococcal Infections/pathology , Staphylococcus epidermidis/drug effects , Staphylococcus epidermidis/growth & development , Staphylococcus epidermidis/isolation & purification , beta-Lactams/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...